Clearance Summary
COMPASS CT, COMPASS CT PORT received FDA 510(k) clearance under submission number K133624, sponsored by Mirador Biomedical. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2014-04-18.
- Submission: K133624
- Applicant / Sponsor: Mirador Biomedical
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.2850
- Decision date: 2014-04-18
Classification & Regulation
This clearance is catalogued under FDA product code DRS and 21 CFR 870.2850, within the Cardiovascular review panel as a Class II device.